Lu Deborah L, Collison Angela M, Kowalski Thomas J
Frommer Lawrence & Haug LLP, 745 Fifth Avenue, New York, New York 10151, USA.
Nat Biotechnol. 2005 Sep;23(9):1079-80. doi: 10.1038/nbt0905-1079.
Recent US case law attempts to further clarify the written description, novelty and non-obviousness requirements as they apply to antibodies
美国近期的判例法试图进一步阐明书面描述、新颖性和非显而易见性要求在适用于抗体时的情况。